IgV somatic mutation of human anti–SARS-CoV-2 monoclonal antibodies governs neutralization and breadth of reactivity
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IgV somatic mutation of human anti–SARS-CoV-2 monoclonal antibodies governs neutralization and breadth of reactivity
Authors
Keywords
-
Journal
JCI Insight
Volume 6, Issue 9, Pages -
Publisher
American Society for Clinical Investigation
Online
2021-03-26
DOI
10.1172/jci.insight.147386
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
- (2020) Alba Grifoni et al. CELL
- Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals
- (2020) Ling Ni et al. IMMUNITY
- SARS‐CoV‐2 viral spike G614 mutation exhibits higher case fatality rate
- (2020) Manuel Becerra‐Flores et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- A Review of SARS-CoV-2 and the Ongoing Clinical Trials
- (2020) Yung-Fang Tu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
- (2020) Chenguang Shen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The convalescent sera option for containing COVID-19
- (2020) Arturo Casadevall et al. JOURNAL OF CLINICAL INVESTIGATION
- Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
- (2020) Dora Pinto et al. NATURE
- The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity
- (2020) Qianqian Li et al. CELL
- Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies
- (2020) Christopher O. Barnes et al. CELL
- Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells
- (2020) Yunlong Cao et al. CELL
- Convergent antibody responses to SARS-CoV-2 in convalescent individuals
- (2020) Davide F. Robbiani et al. NATURE
- Potently neutralizing and protective human antibodies against SARS-CoV-2
- (2020) Seth J. Zost et al. NATURE
- Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
- (2020) Seth J. Zost et al. NATURE MEDICINE
- Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
- (2020) Alina Baum et al. SCIENCE
- Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
- (2020) Thomas F. Rogers et al. SCIENCE
- Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
- (2020) Philip J. M. Brouwer et al. SCIENCE
- Structural basis of a shared antibody response to SARS-CoV-2
- (2020) Meng Yuan et al. SCIENCE
- Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study
- (2020) Hassan Abolghasemi et al. TRANSFUSION AND APHERESIS SCIENCE
- A Scoping Review of Registered Clinical Trials of Convalescent Plasma for COVID-19 and a Framework for Accelerated Synthesis of Trial Evidence (FAST Evidence)
- (2020) Katina Zheng et al. TRANSFUSION MEDICINE REVIEWS
- Comprehensive mapping of immune perturbations associated with severe COVID-19
- (2020) Leticia Kuri-Cervantes et al. Science Immunology
- Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic Antibodies
- (2020) Arif Hussain et al. BIOMEDICINE & PHARMACOTHERAPY
- Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity
- (2020) Carolyn Rydyznski Moderbacher et al. CELL
- A patient affected by critical COVID-19 pneumonia, successfully treated with convalescent plasma
- (2020) Behzad Einollahi et al. TRANSFUSION AND APHERESIS SCIENCE
- Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection
- (2019) Carl W. Davis et al. CELL
- Computational Evaluation of B-Cell Clone Sizes in Bulk Populations
- (2018) Aaron M. Rosenfeld et al. Frontiers in Immunology
- ImmuneDB, a Novel Tool for the Analysis, Storage, and Dissemination of Immune Repertoire Sequencing Data
- (2018) Aaron M. Rosenfeld et al. Frontiers in Immunology
- An atlas of B-cell clonal distribution in the human body
- (2017) Wenzhao Meng et al. NATURE BIOTECHNOLOGY
- Clonify: unseeded antibody lineage assignment from next-generation sequencing data
- (2016) Bryan Briney et al. Scientific Reports
- The analysis of clonal expansions in normal and autoimmune B cell repertoires
- (2015) Uri Hershberg et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Cryptic B Cell Response to Renal Transplantation
- (2013) R. J. Lynch et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization
- (2013) Florian Klein et al. CELL
- IgBLAST: an immunoglobulin variable domain sequence analysis tool
- (2013) Jian Ye et al. NUCLEIC ACIDS RESEARCH
- Memory B Cell Antibodies to HIV-1 gp140 Cloned from Individuals Infected with Clade A and B Viruses
- (2011) Hugo Mouquet et al. PLoS One
- Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation
- (2010) Hugo Mouquet et al. NATURE
- Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals
- (2009) Johannes F. Scheid et al. NATURE
- Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen
- (2009) Kenneth Smith et al. Nature Protocols
- Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning
- (2007) Thomas Tiller et al. JOURNAL OF IMMUNOLOGICAL METHODS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started